MQM-P lawmaker admitted to hospital after attempted suicide

Doctors say she did not consume lethal dosage which helped save her life

Hafeez Tunio March 06, 2018

KARACHI: A lawmaker of Muttahida Qaumi Movement-Pakistan's (MQM-P) was admitted to a hospital on Monday night after swallowing an unadvisable amount of sedative pills – in an attempted suicide.

Member Provincial Assembly (MPA) Shaiza Farooq was moved to Abbasi Shaheed Hospital where she received successful treatment to bring her out of danger.

According to doctors, the dosage consumed by Shazia was not lethal which helped in saving her life. All her medical reports were normal, however, the doctors said that she is under immense mental stress due to which her health deteriorated.

The doctors said she will be discharged later today.

Patch-up or compromise? MQM-P factions announce joint candidates

The MQM-P lawmaker, who had been under scrutiny after Senate elections results for ‘selling’ her vote to Pakistan Peoples Party (PPP), had written a suicide note before the attempt.

In the note, she swore to not have taken money for her vote. “I have been subjected to baseless allegations,” she wrote. “I have no endurance for it.”

The party’s internal rift resulted in MQM-P securing only one seat at the Senate. Earlier this week MPA Faisal Sabzwari expressed fear of losing the Senate elections due to conflicts ensuing within the party.

In his briefing to media, Sabzwari had said that strife within the party will break up the vote bank and the PPP will emerge as the political beneficiary of this discord.

Sabzwari’s predictions came true as PPP swept Senate elections from Sindh on March 3.


Neelum | 6 years ago | Reply I would have suggested that a bullet to the head would have been a much better option. By taking pills either she is not sure of her action or was hoping that she would be found with pills in her body, be saved and get public sympathy.
Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ